December 13, 2010
WILMINGTON, MA and BOSTON, MA - Implant Sciences Corporation (PINKSHEETS: IMSC) (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security markets, and Security Detection Inc., a global firm that is the largest and most experienced supplier of event security equipment in the U.S, today announced an agreement for Security Detection to [...]
InQ Biosciences to Commercialize Cell Research System in First Quarter 2011
December 13, 2010
HUNTSVILLE, ALABAMA - InQ Biosciences, a provider of innovative technologies for cell growth and research, announced today it will commercially release its InQ Cell Research System during the first quarter of 2011. InQ is the first fully integrated system that creates a high-fidelity in vitro environment for studying stem cells –as well as nerve, brain [...]
Dotmatics Licenses Its Informatics Cloud Solution to Lycera Corporation
December 13, 2010
BISHOPS STORTFORD, UNITED KINGDOM - Dotmatics, a provider of informatics tools and scientific data management solutions to the international pharmaceutical and biotechnology industries, is very pleased to announce that it has licensed its entire Informatics suite to Lycera Corporation, including their own note book. Stephen Gallagher, Chief Executive Officer of Dotmatics said "We have enjoyed [...]
December 13, 2010
Dionex Corporation (NasdaqGS: DNEX) shareholder litigation in connection with alleged unfair takeover offer On December 13, 2010, Dionex Corporation (“Dionex” or the “Company”) announced that it has agreed to sell the Company to Thermo Fisher Scientific (“Thermo Fisher”) (NYSE: TMO). Under the terms of the transaction, Thermo Fisher will acquire all of the outstanding shares [...]
Shareholder Claims Against Dionex Investigated by Goldfarb Branham LLP
December 13, 2010
DALLAS - Goldfarb Branham LLP is investigating whether certain officers and directors of Dionex, Inc. (NASDAQ: DNEX) breached duties to shareholders by entering into a transaction to sell the company for $118.50 per share. Concerned stockholders are welcome to contact securities lawyer Hamilton Lindley at 877-583-2855 or hlindley@goldfarbbranham.com about their rights and remedies. Our proposed [...]
Rigrodsky & Long, P.A. Investigates Dionex Corporation Buyout
December 13, 2010
Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of Dionex Corporation (“Dionex” or the “Company”) (Nasdaq: DNEX) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired by Thermo Fisher Scientific in a transaction with [...]
Kendall Law Group Investigates Dionex Corp. Acquisition for Shareholders
December 13, 2010
DALLAS - Kendall Law Group, led by former federal judge Joe Kendall, is investigating Dionex Corp. (NASDAQ: DNEX) for shareholders in connection with the proposed acquisition by Thermo Fisher Scientific. The national securities firm’s investigation seeks to determine whether Dionex and its Board breached their fiduciary duties by entering into the agreement without properly shopping [...]
Thermo Fisher Scientific to Acquire Dionex Corporation
December 13, 2010
• Creates a Leading Chromatography Offering by Adding Dionex's Ion and Liquid Chromatography Portfolio to Thermo Fisher's Existing Chromatography Capabilities • Improves Performance and Productivity for Customers by Combining Thermo Fisher's Leadership in Mass Spectrometry with Dionex's Leading Chromatography Offering • Strengthens Software Growth Platform by Combining Dionex's Gold Standard Chromatography Data System with Thermo [...]
Bruker Receives Order from the University of Utrecht
December 13, 2010
Novel 527 GHz Solid State DNP-NMR System for Research on Membrane Proteins and Protein Complexes UTRECHT, The Netherlands - Bruker announces the first order for a novel and unique 527 GHz Solid State DNP-NMRsystem, based on an ultra-high field NMR system. Dynamic Nuclear Polarization (DNP) has been shown to greatly increase solid-state NMR sensitivity for [...]
Silicon Biosystems Forms U.S. Subsidiary to Commercialize DEPArray™ Technology
December 13, 2010
BOLOGNA, Italy - Silicon Biosystems, S.p.A., a provider of specialized molecular and cell biology technology, today announced that it has formed a U.S. subsidiary operation, Silicon Biosystems, Inc. to be headquartered in San Diego, CA. The newly formed business will focus on commercial operations and the development of the North American research and clinical diagnostics [...]

